Financials

  • Market Capitalization 3.35 B
  • Employee 354
  • Founded 2016
  • CEO Frank Watanabe
  • Website www.arcutis.com
  • Headquarter Delaware, United States
  • FIGI BBG00QN8K4M4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1 178
Rapporto prezzo/fatturato
0.03

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1616
DYN
Dyne Therapeutics, Inc. - Common Stock
23.78 USD+0.59%+1.62%+26.96%+1.58%3.40 B USD
1627
ALMS
Alumis Inc. - Common Stock
27.28 USD-2.92%-6.16%+18.20%+504.88%3.37 B USD
1657
IDYA
IDEAYA Biosciences, Inc. - Common Stock
36.65 USD+1.38%-7.94%+21.20%+12.49%3.22 B USD
1665
BEAM
Beam Therapeutics Inc. - Common Stock
30.89 USD-0.35%-15.21%-0.74%+56.33%3.18 B USD

Notizie